YETZONE T "CEFTRIAXONE 1gm. IP + TAZOBACTAM 125mg. IP

Yetzone T is an injection of Ceftriaxone and Tazobactam used for treating bacterial infections caused by susceptible bacteria. Main uses: treatment of lower respiratory tract infections caused by susceptible bacteria; treatment of urinary tract infections caused by susceptible bacteria; treatment of skin and soft tissue infections caused by susceptible bacteria; treatment of intra-abdominal infections caused by susceptible bacteria; treatment of pelvic infections caused by susceptible bacteria.

Common side effects of Yetzone T Injection include diarrhoea or loose stools; pain, redness, swelling or induration at the injection site; rash; nausea or vomiting; phlebitis after intravenous administration; eosinophilia or raised platelet count. Get medical help at once if you notice severe allergic reaction (anaphylaxis) with breathing difficulty or swelling of the face, throat or tongue; severe skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis; pseudomembranous colitis with severe or bloody diarrhoea during or after treatment.

Yetzone T Injection contains Ceftriaxone 1 g + Tazobactam 125 mg. Yetzone T Injection is given by a doctor or nurse, who decides the dose and how often it is given.

The MRP of Yetzone T Injection is ₹197.81 for a pack of 1.125gm. For chemists and distributors, the PTR is ₹150.71 and the PTS is ₹135.64.

Yetzone T Injection contains Ceftriaxone 1 g + Tazobactam 125 mg. It comes in a pack of 1.125gm.

In this combination, Ceftriaxone acts on the bacterial cell wall and stops the growth of susceptible bacteria. Tazobactam supports it by inhibiting beta-lactamase enzymes, which are the enzymes that certain bacteria release to destroy antibiotics. By blocking these enzymes, Tazobactam helps Ceftriaxone stay active against bacteria that produce them.

Must not be used by patients with known hypersensitivity to Ceftriaxone, Tazobactam, any cephalosporin or the excipients of this injection. Must not be used in premature neonates up to a post-menstrual age of 41 weeks. Must not be used in hyperbilirubinemic neonates. Must not be used in neonates who require calcium-containing intravenous solutions. Check with a doctor first if you are allergic to penicillin or other beta-lactam medicines (extra care is needed as the reaction risk is higher), are pregnant or breastfeeding, have kidney or liver disease, or have a history of colitis.

Yetzone T Injection is a brand of Vibcare Pharma, sold through its Auspin division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.